mycophenolic acid on donor specific hla antibody strength in kidney transplant recipients
Published 14 years ago • 988 plays • Length 2:57Download video MP4
Download video MP3
Similar videos
-
41:45
epidemiology of de-novo donor specific anti-hla antibodies from the ecu transplant study
-
53:54
the clinical pharmacology of mycophenolic acid in kidney transplant recipients
-
19:52
post-transplant antibodies as a marker for rejection
-
3:39
pretransplant cpra and kidney allograft survival
-
18:38
mycophenolate versus azathioprine for maintenance in anca-associated vasculitis: the improve trial
-
29:13
nicolae leca, md - immune monitoring – path to individualizing immunosuppression in transplantation
-
26:42
cynthia kramer: generation & reactivity analysis of recombinant mabs against epitopes on hla-dr
-
1:15:41
immunosuppression minimization how biomarkers can play a role
-
19:30
mycophenolate versus azathioprine for maintenance in lupus nephritis: the alms maintenance trial
-
3:57
presurgical testing for kidney transplantation
-
8:37
introduction to renal transplantation
-
1:02:28
kidney transplantation: an internist's perspective
-
42:39
hla in transplantation
-
3:36
conversion of renal allograft recipients to a bioequivalent cyclosporine formulation
-
56:46
genomics of kidney disease webinar: transplant nephrology
-
5:32
immunosuppressive management of the kidney transplant recipient
-
1:07:12
larissa myaskovsky, phd - enhancing equity in kidney transplantation
-
1:37
transplantation of single pediatric kidneys